EVP R&D, Chief Medical Officer
Sun, Feb 23, 2025
Feb 23
3,414 shares @ $35.32
Decreased holdings by -4.40%
Net across this filing: +17.70% (+11,102 shares)
48th largest trade (out of 157)
Tax Withholding
Trade made by an officer
Shares withheld by the issuer to cover taxes on vesting — not a market sale
Net holdings across this filing: +17.7% (+11,102 shares)